DexCom, Inc.  a global leader in continuous glucose monitoring, announced Dexcom Flex, a new CGM system designed specifically for adults with Type 2 diabetes who are not using intensive insulin...

ACIST Medical Systems, Inc., a Bracco company and a global leader in advanced contrast management technologies, announced U.S. Food and Drug Administration (FDA) clearance and U.S. launch of the...

Triquetra Health, a clinical-grade supplement company developing evidence-based nutritional formulas, announced the launch of FolinicActive™ Adult 1 mg, a multi-pathway active folate supplement combining...

In recognition of World Hypertension Day 2026 on May 17th, Recor Medical, Inc. ("Recor"), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., joins the global community in raising...

Novarè Injury Care and Rehab has expanded its accident injury services at its Fort Myers location, bringing more than $2 million in specialized recovery equipment and advanced rehabilitation...

PLT Health Solutions, Inc. announced that Grow in Health S.L., a Spanish nutraceutical company focused on pharmaceutical-style formulations for performance and healthy aging, has launched a new joint...

ZEISS Medical Technology announced that Mexico's Comisión Federal para la Protección contra Riesgos Sanitários (COFEPRIS) approved the ARTEVO® 850 ophthalmic microscope from ZEISS and the MICOR® 700 from...

Bimini Health Tech, a global leader in medical technologies for women's health, announced the achievement of EU Medical Device Regulation (MDR) certification for the company. The achievement marks a...

Boots has launched a new pilot Bone Density Scan Service utilizing Bindex ultrasound technology. With the Bindex device, osteoporosis risk can be detected in a quick assessment available at selected...

Owlet, Inc. the pioneer of smart infant monitoring, announced the launch of Dream Sight and Dream Duo 3 across Australia and New Zealand. The expansion builds on the Company’s 2025 Dream Sock launch...

SQ Innovation announced topline results from the SUBCUT HF II trial of its product Lasix® ONYU, a novel subcutaneous formulation of furosemide for people with heart failure-associated...

For millions of parents, every snack, restaurant meal or birthday party comes with the same worry: Can my child eat this.